Tender Results of Nhs England

National Sickle Cell and Thalassemia Blood Group Genotyping Programme-The proposed 12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia.

Downs Syndrome Screening Quality Assurance Support Service (DQASS)-supplier for the provision of a Down's Syndrome Screening Quality Assurance Support Service (DQASS). The service is a clinical statistical support service to support the Down's syndrome (T21) Edwards' syndrome (T18) and Patau's syndrome (T13) screening programme by providing independent audits of screening laboratory and ultrasound data in a standardised and statistically valid format. The service will is led by and include staff who are statisticians and are experts, experi...

Digital First OCVC Framework Management-Ongoing management of Digital First Online Consultations and Video Consultations framework (DFOCVC), sitting under the Digital Care Services (DCS) framework which is operated by NHS Digital for NHS Buyer organisations.

Covid 19 - LGA to support the Demand Team of the national NHSE VDP-The provision, by the Supplier, of support to the Demand Team within NHSE&I to encourage greater engagement between local government and the VDP, to develop understanding of the role of local government and its potential within the programme and to support a clearer role in supporting the delivery of Phase 3 and next steps, including embedding Covid-19 vaccinations into a new business as usual as and when guidelines and policy are produced to guide this.

Hepatitis C National Testing Portal-Testing portal with the facility to engage people testing positive to their local ODN specialist clinical team

Hepatitis C National Testing Portal-Open Procedure to procure the design, build and implementation of a National Testing Portal for HEP C patients

Cancer Quality of Life Metric: Data collection 2024-28-To deliver the Cancer Quality of Life (QoL) Survey over its next phase, 2024-2028. The QoL Survey is drawn from the 2019 NHS Long Term Plan for Cancer to introduce an innovative quality of life metric to track and respond to the long-term impact of cancer.

National Cancer Patient Experience Survey 2025-2029-The 2025-2029 contract will include preparation of the survey materials; sending out questionnaires; receiving and managing responses and producing outputs. The survey currently uses a 'mixed mode' methodology. Questionnaires are sent by post and two reminder letters are sent to non-responders. Each letter includes information about how to complete the questionnaire online. The current survey results are actively used by providers, Cancer Alliances and charities to identify where ca...

GRAIL Digital Infrastructure to support Galleri testing-In December 2020, NHS England entered into a commercial agreement with GRAIL to test and rapidly deploy their Galleri Multi-Cancer Early Detection (MCED) test. The agreement commits NHSE to deploy 1,000,000 Galleri tests across the years 2024 and 2025 on the condition that the interim results of the trial meet certain strict conditions. This programme has been termed the ‘Interim Implementation Pilot’. The success of the 2024 programme will be dependent on a delivery model that is underpinned...

NHS National Framework for Transition products commencing 1 May 2024-Project title: NHS National Framework for Transition products commencing 1 May 2024 Offer reference number: CM/TNS/05/2024 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months) Lot 2 CESW: 01/05/2024 to 30/...